Gastrointestinal
Advancing Formulations for Localized and Systemic GI Therapies
At MedPharm, we specialize in the development of innovative drug products targeting the gastrointestinal (GI) tract, with expertise spanning topical GI treatments to systemic therapies delivered via mucosal absorption. Whether you are formulating for localized conditions or systemic bioavailability through oral mucosal, esophageal, or rectal delivery, our team applies a science-driven approach to maximize therapeutic outcomes.
We understand the unique challenges of delivering drugs to the GI tract—such as variable pH, enzymatic degradation, mucosal barriers, and transit times—and we design our formulations to overcome these complexities with precision and performance.
